Hasil Pencarian - Jorge Mestre-Ferrándiz
- Menampilkan 1 - 8 hasil dari 8
-
1
Collaboration for new therapies: maximizing health and innovation oleh Jorge Mestre-Ferrandiz, Pierre Meulien, Dennis A. Ostwald, Virginia Acha
Diterbitkan 2024-09-01
Artikel -
2
An analysis of orphan medicine expenditure in Europe: is it sustainable? oleh Jorge Mestre-Ferrandiz, Christina Palaska, Tom Kelly, Adam Hutchings, Adam Parnaby
Diterbitkan 2019-12-01
Artikel -
3
Comparing access to orphan medicinal products in Europe oleh Bernarda Zamora, Francois Maignen, Phill O’Neill, Jorge Mestre-Ferrandiz, Martina Garau
Diterbitkan 2019-05-01
Artikel -
4
Not one, but many: developing a multi-indication pricing model for medicines in Belgium oleh Ingrid Maes, Eline Kok, Pieter-Jan De Torck, Jorge Mestre-Ferrandiz, Steven Simoens
Diterbitkan 2023-09-01
Artikel -
5
-
6
Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain oleh Alberto Pérez-Rubio, Jorge Mestre-Ferrandiz, Juan Luis López-Belmonte, Ariadna Diaz-Aguiló, Seila Lorenzo-Herrero, Carlos Crespo
Diterbitkan 2024-08-01
Artikel -
7
Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain oleh Jorge Mestre-Ferrándiz, Agustín Rivero, Alejandro Orrico-Sánchez, Álvaro Hidalgo, Fernando Abdalla, Isabel Martín, Javier Álvarez, Manuel García-Cenoz, Maria del Carmen Pacheco, María Garcés-Sánchez, Néboa Zozaya, Raúl Ortiz-de-Lejarazu
Diterbitkan 2024-01-01
Artikel -
8
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study) oleh Fernando de Andrés-Nogales, Encarnación Cruz, Miguel Ángel Calleja, Olga Delgado, Maria Queralt Gorgas, Jaime Espín, Jorge Mestre-Ferrándiz, Francesc Palau, Alba Ancochea, Rosabel Arce, Raquel Domínguez-Hernández, Miguel Ángel Casado, the FinMHU-MCDA Group
Diterbitkan 2021-04-01
Artikel